The latest closing stock price for Fulcrum Therapeutics as of April 10, 2025 is 2.62.
An investor who bought $1,000 worth of Fulcrum Therapeutics stock at the IPO in 2019 would have $-806 today, roughly -1 times their original investment - a -23.89% compound annual growth rate over 6 years.
The all-time high Fulcrum Therapeutics stock closing price was 30.97 on September 20, 2021.
The Fulcrum Therapeutics 52-week high stock price is 10.13, which is 286.6% above the current share price.
The Fulcrum Therapeutics 52-week low stock price is 2.31, which is 11.8% below the current share price.
The average Fulcrum Therapeutics stock price for the last 52 weeks is 5.40.
An investor who bought $1,000 worth of Fulcrum Therapeutics stock at the IPO in 2019 would have $-806 today, roughly -1 times their original investment - a -23.89% compound annual growth rate over 6 years.
The all-time high Fulcrum Therapeutics stock closing price was 30.97 on September 20, 2021.
The Fulcrum Therapeutics 52-week high stock price is 10.13, which is 286.6% above the current share price.
The Fulcrum Therapeutics 52-week low stock price is 2.31, which is 11.8% below the current share price.
The average Fulcrum Therapeutics stock price for the last 52 weeks is 5.40.